For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Sanbio, Inc.

USPTO Granted Patents = 38

% Expired Patents = 7.9

CIPO Patents = 2

EPO Patents = 19

Forward Citations = 203

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Casey Christopher Case (13 out of 40 patents)

Mari Dezawa (10 out of 28 patents)

Hajime Sawada (8 out of 8 patents)

4. Masahiko Takano (8 out of 8 patents)

5. Irina Aizman (7 out of 7 patents)

6. Hiroshi Kanno (7 out of 81 patents)

7. Mo Dao (5 out of 5 patents)

8. Aline Betancourt (4 out of 6 patents)

9. Ciara C Tate (4 out of 5 patents)

10. Damien Bates (2 out of 2 patents)

11. Toru Kawanishi (2 out of 3 patents)

12. Cesar V Borlongan (2 out of 4 patents)

13. Monique A Dao (2 out of 3 patents)

14. Noriyuki Kuno (2 out of 2 patents)

15. Keita Mori (2 out of 2 patents)

38 patents: Sort by Forward Citations

1. 12553033 - Medium, methods, cells and secreted factors for stem cell culture and therapy (2026-02-17),

2. RE50635 - Neural regenerating cells with alterations in DNA methylation (2025-10-14),

3. 12357761 - Cell delivery system and methods of operation thereof (2025-07-15),

4. 12171787 - Methods and compositions for modulating angiogenesis and vasculogenesis (2024-12-24),

5. 12121544 - Cell therapies and methods of treatment for small-volume stroke (2024-10-22),

6. 11946072 - Medium, methods, cells and secreted factors for stem cell culture and therapy (2024-04-02),

7. 11903972 - Methods and compositions for modulating peripheral immune function (2024-02-20),

8. 11512284 - Neural precursor cells expressing exogenous Notch intracellular domain (2022-11-29),

9. 11439761 - Cell delivery system and methods of operation thereof (2022-09-13),

10. 11406685 - Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of FGF2 isoforms (2022-08-09),

11. 11124771 - MSC growth predictor assays (2021-09-21),

12. 11046929 - Induction medium and methods for stem cell culture and therapy (2021-06-29),

13. 10702554 - Extracellular matrix from pluripotent cells (2020-07-07),

14. 10653724 - Extracellular matrix from pluripotent cells (2020-05-19),

15. 10626389 - Methods and compositions for modulation of migration of neurogenic cells (2020-04-21),

SanBio, Inc. is a biotechnology company focused on regenerative medicine. With a mission to develop innovative therapies for diseases with high unmet medical needs, SanBio aims to restore patient health and improve the quality of life. The company utilizes its unique patented technology to develop cell-based therapeutics targeting neurological disorders, such as stroke and traumatic brain injury. Through extensive research and development, SanBio aims to make a positive impact on patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

38 Patents

#86 in Mountain View, CA

#2,126 in California

#9,008 in US

#17,791 in the World

Mountain View, CA, United States of America

Sanbio, Inc.

Forward Citations = 203

26 inventors:

Casey Christopher Case (13 out of 40 patents)

Mari Dezawa (10 out of 28 patents)

Hajime Sawada (8 out of 8 patents)

4. Masahiko Takano (8 out of 8 patents)

5. Irina Aizman (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…